SMLR INVESTORS: Kirby McInerney LLP Reminds Semler Scientific, Inc. Investors of Important Deadline in Class Action Lawsuit

Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to alleged securities fraud related to undisclosed investigations by the U.S. Department of Justice regarding the QuantaFlo device reimbursement claims [3][5]. Group 1: Company Background - Semler filed its Form 10-K with the SEC on February 28, 2025, revealing an initial civil investigative demand from the DOJ dating back to July 2017 [3]. - The company has received multiple requests for information from the DOJ over the years, with the latest being in April 2023 [3]. Group 2: Financial Impact - Following the disclosure of the DOJ investigation, Semler's share price dropped by $4.03, approximately 9.39%, from $42.92 to $38.89 between February 28 and March 3, 2025 [3]. - After announcing a settlement agreement of $29.75 million on April 15, 2025, Semler's shares fell by $3.40, or about 9.9%, from $34.40 to $31.00 the following day [4]. Group 3: Lawsuit Details - The class action lawsuit is on behalf of investors who purchased Semler securities from March 10, 2021, to April 15, 2025, alleging that the company made false or misleading statements regarding the DOJ investigation [5]. - The lawsuit claims that the company failed to disclose material information about the investigation, leading to investor damages when the truth was revealed [5].